Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial.
Study Goal
The researchers aimed to assess the effects of substituting walnuts for part of the monounsaturated fat in a cholesterol-lowering Mediterranean diet on serum lipid levels and LDL oxidizability in hypercholesterolemic individuals.
Results Summary
The walnut diet significantly reduced total cholesterol (-4.1%), LDL cholesterol (-5.9%), and lipoprotein(a) levels (-6.2%) compared to the Mediterranean diet, with preserved LDL resistance to oxidation. Lipid changes were similar in men and women, except for lipoprotein(a), which decreased only in men.
Population
55 men and women (mean age 56) with polygenic hypercholesterolemia.
Effective Dosage
Walnuts replaced approximately 35% of the energy obtained from monounsaturated fat.
Duration
6 weeks per diet.
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
walnuts | decrease | serum cholesterol levels | normal young men | - | reduce | #1 |
walnuts | neutral | serum lipid levels | free-living hypercholesterolemic persons | - | effects on | #2 |
walnuts | neutral | low-density lipoprotein (LDL) oxidizability | free-living hypercholesterolemic persons | - | effects on | #3 |
walnut diet | decrease | total cholesterol level | men and women with polygenic hypercholesterolemia | -4.1% | produced mean changes of | #4 |
walnut diet | decrease | LDL cholesterol level | men and women with polygenic hypercholesterolemia | -5.9% | produced mean changes of | #5 |
walnut diet | decrease | lipoprotein(a) level | men and women with polygenic hypercholesterolemia | -6.2% | produced mean changes of | #6 |
walnut diet | decrease | total cholesterol level | men and women with polygenic hypercholesterolemia | -0.28 mmol/L (-10.8 mg/dL) | mean differences in the changes | #7 |
walnut diet | decrease | LDL cholesterol level | men and women with polygenic hypercholesterolemia | -0.29 mmol/L (-11.2 mg/dL) | mean differences in the changes | #8 |
walnut diet | decrease | lipoprotein(a) level | men and women with polygenic hypercholesterolemia | -0.021 g/L | mean differences in the changes | #9 |
walnut diet | decrease | lipoprotein(a) levels | men | - | decreased | #10 |
walnuts | increase | Low-density lipoprotein particles with polyunsaturated fatty acids | men and women with polygenic hypercholesterolemia | - | enriched | #11 |
walnuts | no change | Low-density lipoprotein particles | men and women with polygenic hypercholesterolemia | - | resistance to oxidation was preserved | #12 |
Substituting walnuts for part of the mono-unsaturated fat in a cholesterol-lowering Mediterranean diet | decrease | total cholesterol levels | men and women with hypercholesterolemia | - | further reduced | #13 |
Substituting walnuts for part of the mono-unsaturated fat in a cholesterol-lowering Mediterranean diet | decrease | LDL cholesterol levels | men and women with hypercholesterolemia | - | further reduced | #14 |
BACKGROUND: It has been reported that walnuts reduce serum cholesterol levels in normal young men. OBJECTIVE: To assess the acceptability of walnuts and their effects on serum lipid levels and low-density lipoprotein (LDL) oxidizability in free-living hypercholesterolemic persons. DESIGN: Randomized, crossover feeding trial. SETTING: Lipid clinic at a university hospital. PATIENTS: 55 men and women (mean age, 56 years) with polygenic hypercholesterolemia. INTERVENTION: A cholesterol-lowering Mediterranean diet and a diet of similar energy and fat content in which walnuts replaced approximately 35% of the energy obtained from monounsaturated fat. Patients followed each diet for 6 weeks. MEASUREMENTS: Low-density lipoprotein fatty acids (to assess compliance), serum lipid levels, lipoprotein(a) levels, and LDL resistance to in vitro oxidative stress. RESULTS: 49 persons completed the trial. The walnut diet was well tolerated. Planned and observed diets were closely matched. Compared with the Mediterranean diet, the walnut diet produced mean changes of -4.1% in total cholesterol level, -5.9% in LDL cholesterol level, and -6.2% in lipoprotein(a) level. The mean differences in the changes in serum lipid levels were -0.28 mmol/L (95% CI, -0.43 to -0.12 mmol/L) (-10.8 mg/dL [-16.8 to -4.8 mg/dL]) (P<0.001) for total cholesterol level, -0.29 mmol/L (CI, -0.41 to -0.15 mmol/L) (-11.2 mg/dL [-16.3 to -6.1 mg/dL]) (P<0.001) for LDL cholesterol level, and -0.021 g/L (CI, -0.042 to -0.001 g/L) (P = 0.042) for lipoprotein(a) level. Lipid changes were similar in men and women except for lipoprotein(a) levels, which decreased only in men. Low-density lipoprotein particles were enriched with polyunsaturated fatty acids from walnuts, but their resistance to oxidation was preserved. CONCLUSION: Substituting walnuts for part of the mono-unsaturated fat in a cholesterol-lowering Mediterranean diet further reduced total and LDL cholesterol levels in men and women with hypercholesterolemia.